Free shipping on all orders over $ 500

UMI-77

Cat. No. M5226

All AbMole products are for research use only, cannot be used for human consumption.

UMI-77 Structure
Size Price Availability Quantity
5mg USD 92  USD92 In stock
10mg USD 138  USD138 In stock
50mg USD 420  USD420 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

In vitro: UMI-77 effectively disrupts the interactions between BL-Noxa and cellular Mcl-1, as well as Mcl-1/Bax protein–protein interactions. UMI-77 inhibits growth of pancreatic cancer cells with IC50 of 3.4, 4.4, 12.5, 16.1, and 5.5 μM for BxPC-3, Panc-1, MiaPaCa-2, AsPC-1 and Capan-2 cells, respectively. UMI-77 induced apoptosis in pancreatic cancer through activation of the intrinsic apoptotic pathway and/or Bax conformational change. In vivo: In a BxPC-3 xenograft mouse model, UMI-77 (60 mg/kg i.v.) exhibits single-agent antitumor activity without any damage normal tissues.

Protocol (for reference only)
Cell Experiment
Cell lines Human pancreatic cancer cell lines AsPC-1, BxPC-3, Panc-1, MiaPaCa and Capan-2
Preparation method Human pancreatic cancer cell lines AsPC-1, BxPC-3, and Capan-2 are cultured in RPMI-1640 medium, whereas Panc-1 and MiaPaCa are cultured in Dulbeccos' Modified Eagle's Medium (DMEM), all supplemented with 10% FBS. The cell growth inhibition after treatment with increasing concentrations of the compounds is determined by WST-8 assay.
Concentrations ~100 μM
Incubation time 4 days
Animal Experiment
Animal models
Formulation
Dosages
Administration
Chemical Information
Molecular Weight 468.34
Formula C18H14BrNO5S2
CAS Number 518303-20-3
Solubility (25°C) 70 mg/mL in DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Liu JW, et al. Mol Cell Biochem. UMI-77 primes glioma cells for TRAIL-induced apoptosis by unsequestering Bim and Bak from Mcl-1.

[2] Korfi K, et al. Cell Death Dis. BIM mediates synergistic killing of B-cell acute lymphoblastic leukemia cells by BCL-2 and MEK inhibitors.

[3] Abulwerdi F, et al. Mol Cancer Ther. A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo.

Related Bcl-2 Products
ABBV-467 

ABBV-467 is a selective MCL-1 inhibitor (Ki: <0.01 nM).

WEHI-539 

WEHI-539 is a selective inhibitor of Bcl-XL with an IC50 of 1.1 nM.

(Rac)-Lisaftoclax

(Rac)-Lisaftoclax ((Rac)-APG-2575) is a Bcl-2 inhibitor that can be uesd for hematologic malignancy research.

BcI-2/BcI-xI ligand 1 

BcI-2/BcI-xI ligand 1 is a BcI-2/BcI-xI ligand, and can be used for synthesis of PROTAC BcI-2/BcI-xI Degrader-1.

AZD-5991 (S-enantiomer) 

AZD-5991 S-enantiomer is the less active enantiomer of AZD-5991.

  Catalog
Abmole Inhibitor Catalog




Keywords: UMI-77 supplier, Bcl-2, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.